Johnson & Johnson announces definitive agreement to acquire Aragon Pharmaceuticals, Inc.
17 June 2013 | By Johnson & Johnson
Late-stage prostate cancer treatment strengthens oncology pipeline...
List view / Grid view
17 June 2013 | By Johnson & Johnson
Late-stage prostate cancer treatment strengthens oncology pipeline...
17 June 2013 | By Gilead Sciences, Inc.
Gilead Sciences announced interim results from a single-arm, open-label Phase 2 study evaluating idelalisib...
17 June 2013 | By Boehringer Ingelheim
New long-term data from the RELY-ABLE® study...
17 June 2013 | By Teva Pharmaceutical Industries Ltd.
Teva has entered into a definitive agreement to acquire MicroDose Therapeutx...
17 June 2013 | By BMG LABTECH
Over the years, many different assays have been designed...
17 June 2013 | By AstraZeneca
MedImmune and NGM Biopharmaceuticals have entered into an exclusive agreement...
17 June 2013 | By Novartis
The Novartis Prizes for Immunology are awarded to three scientists...
17 June 2013 | By Roche
First approval of Avastin for the treatment of newly diagnosed glioblastoma...
16 June 2013 | By Novartis
Results from a Phase III three-year follow-up study...
13 June 2013 | By Amgen
XGEVA becomes first FDA-approved treatment for this rare disease...
13 June 2013 | By Boehringer Ingelheim
Data from interferon-free SOUND-C3 study...
13 June 2013 | By Roche
Roche announced data from two phase III studies...
12 June 2013 | By bioMérieux
A wide range of BioBall® products to meet diverse customer needs...
12 June 2013 | By Amgen
Study meets primary endpoint of progression-free survival...
12 June 2013 | By Amgen
Amgen and Cytokinetics announced an expansion of their strategic collaboration...